Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Patricia Jumes
Grazoprevir, Ruzasvir, and Uprifosbuvir for HCV After NS5A Treatment Failure
Hepatology
Medicine
Hepatology
Pharmacokinetic Interactions Between the HCV Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, or Darunavir in Healthy Participants
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
In Vitro Antiviral Profile of Ruzasvir: A Potent and Pan-Genotype Inhibitor of HCV NS5A
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
The Efficacy and Safety of Elbasvir/Grazoprevir Treatment in HCV Genotype 1 Patients in Taiwan
Journal of Medical Virology
Virology
Infectious Diseases
Elbasvir/Grazoprevir and Sofosbuvir for HCV Genotype 3 Infection With Compensated Cirrhosis: A Randomized Trial
Hepatology
Medicine
Hepatology
Perilipin 5 Alleviates HCV NS5A-induced Lipotoxic Injuries in Liver
Lipids in Health and Disease
Biochemistry
Endocrinology
Clinical Biochemistry
Metabolism
Diabetes
Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy
Gastroenterology
Hepatology
Gastroenterology
NS5A-P32 Deletion After Failure of Ledipasvir/Sofosbuvir in Hepatitis C Virus Genotype 1b Infection
Hepatology
Medicine
Hepatology
Heart Failure After Treatment for Breast Cancer
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
Antiviral Activity and Resistance Analysis of NS3/4A Protease Inhibitor Grazoprevir and NS5A Inhibitor Elbasvir in Hepatitis C Virus GT4 Replicons
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Late‐onset Heart Failure After Treatment for Breast Cancer
Cancer
Cancer Research
Oncology
